Allon Therapeutics, Inc. operates as a clinical-stage biotechnology company, which engages in the development of drugs to treat neurodegenerative diseases and disorders. It focuses and provides central nervous system therapies. The company was founded by Illana Gozes and Richard P. Burgoon on March 24, 1994 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Allon Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Allon Therapeutics Inc. 52 week high is $0.0001 as of October 10, 2025.
What is the 52-week low for Allon Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Allon Therapeutics Inc. 52 week low is $0.0001 as of October 10, 2025.
What is Allon Therapeutics Inc. stock price today?
Allon Therapeutics Inc. stock price today is $0.0001.
What is the 50-day moving average of Allon Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Allon Therapeutics Inc. 50-day moving average is $0.0001.